Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Understand the usual disbursement timing after refinance approval and actions that can speed or delay access to funds.
21,084 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Investors are weighing a 32% drop in Netflix stock since April after Reed Hastings signaled a board exit. Here’s how ...
A top Wells Fargo strategist urges retail investors to look for buying opportunities on market dips sparked by Fed ti...
Webull trades in the mid-$6s as analysts outline a possible 50% jump within 12 months, driven by stronger revenue, ex...
American Express has carved a niche by serving high-spending clients with premium perks. This article explores whethe...
Micron Technology posted blowout Q3 2026 results, sending shares higher and lifting SanDisk and Western Digital as in...
Three Buy-rated names are drawing fresh attention in June as Wall Street echoes a defensive, cash-flow bias. AutoZone...
Investors are watching amazon's next move into big-box retail with caution and curiosity. This article breaks down wh...
Two tech giants pull back in divergent fashion. This report analyzes valuations, AI upside, and cash flow to help ret...
California Gov. Gavin Newsom unveils a national wealth tax plan and a federal stake in AI firms, as a California ball...
MercadoLibre dominates LATAM e-commerce and fintech, but the stock has pulled back from its peak. This guide explains...
Investors are buzzing about a big quarter from Micron. In micron's explosive earnings report:, the company posted a p...